7 research outputs found
Emamectin benzoate (Proclaim®) mediates biochemical changes and histopathological damage in the kidney of male Wistar rats (Rattus norvegicus)
Dissipation of antibiotics by microalgae: Kinetics, identification of transformation products and pathways
The potential of calcium carbide waste and termite mound soil as materials in the production of unfired clay bricks
Objective and noninvasive biochemical markers in rheumatoid arthritis: where are we and where are we going?
Postdural puncture headache in obstetric neuraxial anaesthesia: Current evidence and therapy
Microalgae-based technology for antibiotics removal: From mechanisms to application of innovational hybrid systems
Recommended from our members
Advancing patient care through the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR)
Recent advances in rare disease research are accelerated by the work of consortia that have been supported by the National Institutes of Health. Development of such consortia rely on multidisciplinary relationships and engagement with patient advocacy groups, as well as the National Institutes of Health and industry and academic partners. In this rostrum we present the development of such a process that focuses on eosinophilic gastrointestinal diseases. Principal investigators, patient advocacy groups, research assistants, and trainees work together to perform natural history studies that promote clinical trial readiness tools, conduct clinical trials, train a new generation of investigators, and perform innovative pilot studies